HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells (Q24299220)

https://api.crossref.org/works/10.1002%2FPROS.20558

Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

Heat-shock protein 27: a potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine op

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Protein analysis by mass spectrometry and sequence database searching: tools for cancer research in the post-genomic era.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Identification of proteins in human prostate tumor material by two-dimensional gel electrophoresis and mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Glycosylation of urinary prostate-specific antigen in benign hyperplasia and cancer: assessment by lectin-binding patterns

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Heat shock proteins: their role in urological tumors

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

The pattern of CD10 expression in selected pathologic entities of the prostate gland

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Emerging tandem-mass-spectrometry techniques for the rapid identification of proteins

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

A statistical model for identifying proteins by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5' untranslated regions

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

The application of new software tools to quantitative protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry: II. Evaluation of tandem mass spectrometry methodologies for large-scale protein analysis, and the applicatio

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

The small heat shock proteins and their role in human disease.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Transcriptomes of human prostate cells

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1002%2FPROS.20558

7 January 2021